Product NDC: | 65250-266 |
Proprietary Name: | EXPAREL |
Non Proprietary Name: | bupivacaine |
Active Ingredient(s): | 13.3 mg/mL & nbsp; bupivacaine |
Administration Route(s): | INFILTRATION |
Dosage Form(s): | INJECTION, SUSPENSION, LIPOSOMAL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65250-266 |
Labeler Name: | Pacira Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022496 |
Marketing Category: | NDA |
Start Marketing Date: | 20120101 |
Package NDC: | 65250-266-20 |
Package Description: | 10 VIAL in 1 CARTON (65250-266-20) > 20 mL in 1 VIAL |
NDC Code | 65250-266-20 |
Proprietary Name | EXPAREL |
Package Description | 10 VIAL in 1 CARTON (65250-266-20) > 20 mL in 1 VIAL |
Product NDC | 65250-266 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bupivacaine |
Dosage Form Name | INJECTION, SUSPENSION, LIPOSOMAL |
Route Name | INFILTRATION |
Start Marketing Date | 20120101 |
Marketing Category Name | NDA |
Labeler Name | Pacira Pharmaceuticals Inc. |
Substance Name | BUPIVACAINE |
Strength Number | 13.3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |